Author:
Yu Hyunmin,Bauermeister José,Oyiborhoro Ufuoma,Morales Knashawn,Aryal Subhash,Glanz Karen,Villarruel Antonia,Bonett Stephen
Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533–4. https://doi.org/10.1016/S1473-3099(20)30120-1.
2. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33. https://doi.org/10.1056/NEJMoa2001017.
3. World Health Organization. WHO COVID-19 solidarity therapeutics trial 2024. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments. Accessed 15 March 2024.
4. Babaei F, Mirzababaei M, Nassiri-Asl M, Hosseinzadeh H. Review of registered clinical trials for the treatment of COVID‐19. Drug Dev Res. 2021;82(4):474–93. https://doi.org/10.1002/ddr.21762.
5. Duarte M, Pelorosso F, Nicolosi LN, Salgado MV, Vetulli H, Aquieri A, et al. Telmisartan for treatment of COVID-19 patients: an open multicenter randomized clinical trial. eClin Med. 2021;37. https://doi.org/10.1016/j.eclinm.2021.100962.